14.79
price up icon0.20%   +0.03
after-market  After Hours:  14.78  -0.010   -0.07%
loading
Bausch + Lomb Corp stock is currently priced at $14.79, with a 24-hour trading volume of 180.46K. It has seen a +0.20% increased in the last 24 hours and a -12.59% declined in the past month. The chart indicates a potential bearish trend, as the stock is below the $14.80 pivot point. If it approaches the $14.66 support level, significant changes may occur.
Previous Close:
$14.76
Open:
$14.8
24h Volume:
180.46K
Market Cap:
$5.19B
Revenue:
$4.15B
Net Income/Loss:
$-260.00M
P/E Ratio:
-24.95
EPS:
-0.5929
Net Cash Flow:
$-198.00M
1W Performance:
+1.02%
1M Performance:
-12.59%
6M Performance:
-6.98%
1Y Performance:
-12.74%
1D Range:
Value
$14.65
$14.85
52W Range:
Value
$13.62
$21.95

Bausch + Lomb Corp Stock (BLCO) Company Profile

Name
Name
Bausch + Lomb Corp
Name
Phone
905-695-7700
Name
Address
520 Applewood Crescent, Vaughan
Name
Employee
19,600
Name
Twitter
Name
Next Earnings Date
2024-05-14
Name
Latest SEC Filings
Name
BLCO's Discussions on Twitter

Bausch + Lomb Corp Stock (BLCO) Upgrades & Downgrades

Date Action Analyst Rating Change
Jan-04-24 Downgrade Evercore ISI Outperform → In-line
Dec-12-23 Initiated Stifel Hold
Oct-03-23 Resumed Evercore ISI Outperform
May-30-23 Resumed Morgan Stanley Equal-Weight
Mar-09-23 Initiated Needham Hold
Dec-21-22 Initiated Barclays Equal Weight
Sep-12-22 Initiated H.C. Wainwright Buy
Jul-26-22 Initiated RBC Capital Mkts Outperform
Jun-24-22 Initiated Evercore ISI Outperform
Jun-06-22 Initiated Citigroup Buy
May-31-22 Initiated Deutsche Bank Hold
May-31-22 Initiated Goldman Neutral
May-31-22 Initiated Guggenheim Buy
May-31-22 Initiated JP Morgan Neutral
May-31-22 Initiated Jefferies Buy
May-31-22 Initiated Morgan Stanley Equal-Weight
May-31-22 Initiated Wells Fargo Overweight
May-11-22 Initiated Cowen Outperform
View All

Bausch + Lomb Corp Stock (BLCO) Financials Data

Bausch + Lomb Corp (BLCO) Revenue 2024

BLCO reported a revenue (TTM) of $4.15 billion for the quarter ending December 31, 2023, a +10.03% rise year-over-year.
loading

Bausch + Lomb Corp (BLCO) Net Income 2024

BLCO net income (TTM) was -$260.00 million for the quarter ending December 31, 2023, a -4,433% decrease year-over-year.
loading

Bausch + Lomb Corp (BLCO) Cash Flow 2024

BLCO recorded a free cash flow (TTM) of -$198.00 million for the quarter ending December 31, 2023, a -216.47% decrease year-over-year.
loading

Bausch + Lomb Corp (BLCO) Earnings per Share 2024

BLCO earnings per share (TTM) was -$0.74 for the quarter ending December 31, 2023, a -5,275% decline year-over-year.
loading
Bausch + Lomb Corporation operates as an eye health company in Canada and internationally. It operates through three segments: Vision Care/Consumer Health Care, Ophthalmic Pharmaceuticals, and Surgical. The Vision Care/Consumer Health Care segment provides contact lens that cover the spectrum of wearing modalities, including daily disposable and frequently replaced contact lenses; and contact lens care products, over-the-counter eye drops, eye vitamins, and mineral supplements that address various conditions comprising eye allergies, conjunctivitis, and dry eye. The Ophthalmic Pharmaceuticals segment offers proprietary and generic pharmaceutical products for post-operative treatments and treatments for various eye conditions, such as glaucoma, eye inflammation, ocular hypertension, dry eyes, and retinal diseases; and and contact lenses for therapeutic use. The Surgical segment provides medical device equipment, consumables, and instrumental tools and technologies for the treatment of corneal, cataracts, and vitreous and retinal eye conditions. The company was founded in 1853 and is headquartered in Vaughan, Canada.
medical_instruments_supplies ATR
$143.33
price up icon 2.25%
medical_instruments_supplies TFX
$206.71
price up icon 0.00%
medical_instruments_supplies COO
$88.84
price down icon 1.21%
$75.98
price up icon 0.36%
medical_instruments_supplies BAX
$40.13
price down icon 0.25%
medical_instruments_supplies WST
$360.43
price down icon 2.10%
Cap:     |  Volume (24h):